These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19969602)

  • 1. Should boys receive the human papillomavirus vaccine? Yes.
    Hibbitts S
    BMJ; 2009 Dec; 339():b4928. PubMed ID: 19969602
    [No Abstract]   [Full Text] [Related]  

  • 2. Should boys receive the human papillomavirus vaccine? No.
    Cuschieri K
    BMJ; 2009 Dec; 339():b4921. PubMed ID: 19969601
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of HPV-associated neoplasias by vaccination - short version of the German S3 (level 3) guideline].
    Gross G; Gissmann L; Hillemanns P; Ikenberg H; Kaufmann AM; Petry KU; Pfister H; Schneede P; Schneider A; Smola S;
    Dtsch Med Wochenschr; 2010 May; 135(21):1083-6. PubMed ID: 20486060
    [No Abstract]   [Full Text] [Related]  

  • 4. Merck hopes to extend gardasil vaccine to men.
    Chitale R
    J Natl Cancer Inst; 2009 Feb; 101(4):222-3. PubMed ID: 19211446
    [No Abstract]   [Full Text] [Related]  

  • 5. A brief history of economic evaluation for human papillomavirus vaccination policy.
    Beutels P; Jit M
    Sex Health; 2010 Sep; 7(3):352-8. PubMed ID: 20719227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merck aims for male Gardasil.
    AIDS Read; 2009 May; 19(5):176. PubMed ID: 19557939
    [No Abstract]   [Full Text] [Related]  

  • 7. Should HPV vaccine be given to men?
    Castle PE; Scarinci I
    BMJ; 2009 Oct; 339():b4127. PubMed ID: 19815585
    [No Abstract]   [Full Text] [Related]  

  • 8. Who should get the HPV vaccine? Usage expands amid debate.
    Peres J
    J Natl Cancer Inst; 2010 Jun; 102(12):838-40. PubMed ID: 20530765
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccinate boys as well as girls against HPV: it works, and it may be cost effective.
    Prue G
    BMJ; 2014 Jul; 349():g4834. PubMed ID: 25073786
    [No Abstract]   [Full Text] [Related]  

  • 10. Focus on research: weighing the benefits and costs of HPV vaccination of young men.
    Kim JJ
    N Engl J Med; 2011 Feb; 364(5):393-5. PubMed ID: 21288093
    [No Abstract]   [Full Text] [Related]  

  • 11. The prophylactic role for the human papillomavirus quadrivalent vaccine in males.
    Yancey AM; Pitlick JM; Forinash AB
    Ann Pharmacother; 2010; 44(7-8):1314-8. PubMed ID: 20501891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus and genital cancer.
    Rapose A
    Indian J Dermatol Venereol Leprol; 2009; 75(3):236-43; quiz 243-4. PubMed ID: 19439875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus vaccine: recommendations, issues and controversies.
    Fisher R; Darrow DH; Tranter M; Williams JV
    Curr Opin Pediatr; 2008 Aug; 20(4):441-5. PubMed ID: 18622201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic impact of HPV vaccines: not just cervical cancer.
    Myers ER
    Am J Obstet Gynecol; 2008 May; 198(5):487-8. PubMed ID: 18455522
    [No Abstract]   [Full Text] [Related]  

  • 15. The cost-effectiveness of male HPV vaccination in the United States.
    Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
    Vaccine; 2011 Oct; 29(46):8443-50. PubMed ID: 21816193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
    Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
    Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands.
    Bogaards JA; Coupé VM; Meijer CJ; Berkhof J
    Vaccine; 2011 Nov; 29(48):8929-36. PubMed ID: 21945961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global human papillomavirus vaccination: can it be cost-effective?
    Crosbie EJ
    BJOG; 2012 Jan; 119(2):125-8. PubMed ID: 22168760
    [No Abstract]   [Full Text] [Related]  

  • 19. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
    Goldie SJ; O'Shea M; Diaz M; Kim SY
    Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of Human Papillomavirus (HPV) vaccination in the Netherlands: recent publication reinforces favorable cost-effectiveness despite misleading conclusion.
    Postma MJ
    Vaccine; 2010 Jan; 28(4):873-4. PubMed ID: 19896454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.